SURVYR
Third-party analyst actions

Analyst moves

Upgrades, downgrades, new coverage and price-target changes from Wall Street firms on the stocks we cover. What each firm published, laid out plainly. These are third-party actions, not our views.

Try one

251 moves · this week

ⓘ Rating colors
  • Strong BuyConviction Buy, Top Pick, Top Pick Buy
  • BuyLong Term Buy, Speculative Buy, Outright Buy
  • OutperformOverweight, Accumulate, Moderate Buy, Positive
  • HoldNeutral, Equal Weight, Market Perform, Sector Perform
  • UnderperformUnderweight, Reduce, Moderate Sell, Negative
  • Sell
  • Strong Sell
  • OtherRatings we can't place on the scale

Each firm's own wording is placed on one seven-step scale so ratings compare at a glance. ▲ / ▼ between two ratings marks an upgrade or a downgrade. The colours describe what the firm said; they are not our view.

Yesterday · Oct 27, 2026

Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$526 → $487 −7.4% · −$39
Price at note$410.39 (Oct 27 close) +18.7% upside (+$76.61) to the $487 target
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$529 → $531 +0.4% · +$2
Price at note$410.39 (Oct 27 close) +29.4% upside (+$120.61) to the $531 target
B of A Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$368 → $330 −10.3% · −$38
Price at note$201.28 (Oct 27 close) +64.0% upside (+$128.72) to the $330 target
TLNTalen EnergyOur stock$345.73
Barclays Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$408 → $387 −5.1% · −$21
Price at note$345.73 (Oct 27 close) +11.9% upside (+$41.27) to the $387 target
Rosenblatt Reiterated▲ Target raised
RatingBuy unchanged
Price target$225 → $260 +15.6% · +$35
Price at note$198.73 (Oct 27 close) +30.8% upside (+$61.27) to the $260 target
PAYCPaycomOur stock$261.94
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$194 → $279 +43.8% · +$85
Price at note$261.94 (Oct 27 close) +6.5% upside (+$17.06) to the $279 target
PAYCPaycomOur stock$261.94
Jefferies Reiterated▲ Target raised
RatingHold unchanged
Price target$160 → $300 +87.5% · +$140
Price at note$261.94 (Oct 27 close) +14.5% upside (+$38.06) to the $300 target
Citigroup ▲ Upgrade▼ Target lowered
RatingNeutral▲Buy
Price target$2,100 → $2,050 −2.4% · −$50
Price at note$1,680.51 (Oct 27 close) +22.0% upside (+$369.49) to the $2,050 target
BNP Paribas Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$43 → $35 −18.6% · −$8
Price at note$16.98 (Oct 27 close) +106.1% upside (+$18.02) to the $35 target
Susquehanna Reiterated▲ Target raised
RatingPositive unchanged
Price target$55 → $60 +9.1% · +$5
Price at note$52.27 (Oct 27 close) +14.8% upside (+$7.73) to the $60 target
BMO Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$56 → $46 −17.9% · −$10
Price at note$38.53 (Oct 27 close) +19.4% upside (+$7.47) to the $46 target
CEGConstellation EnergyOur stock$258.98
TD Cowen Reiterated▲ Target raised
RatingBuy unchanged
Price target$368 → $374 +1.6% · +$6
Price at note$258.98 (Oct 27 close) +44.4% upside (+$115.02) to the $374 target
CEGConstellation EnergyOur stock$258.98
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$324 → $345 +6.5% · +$21
Price at note$258.98 (Oct 27 close) +33.2% upside (+$86.02) to the $345 target
BMO Capital Reiterated▼ Target lowered
RatingMarket Perform unchanged
Price target$134 → $124 −7.5% · −$10
Price at note$114.26 (Oct 27 close) +8.5% upside (+$9.74) to the $124 target

Monday · Oct 26, 2026

Barclays ▲ Upgrade▲ Target raised
RatingEqual-Weight▲Overweight
Price target$370 → $450 +21.6% · +$80
Price at note$391.62 (Oct 26 close) +14.9% upside (+$58.38) to the $450 target
HC Wainwright & Co. Reiterated▲ Target raised
RatingBuy unchanged
Price target$66 → $68 +3.0% · +$2
Price at note$67.16 (Oct 26 close) +1.3% upside (+$0.84) to the $68 target
Rosenblatt Reiterated▲ Target raised
RatingBuy unchanged
Price target$80 → $105 +31.2% · +$25
Price at note$86.31 (Oct 26 close) +21.7% upside (+$18.69) to the $105 target
PAYCPaycomOur stock$261.94
BTIG Reiterated▲ Target raised
RatingBuy unchanged
Price target$230 → $305 +32.6% · +$75
Price at note$268.25 (Oct 26 close) +13.7% upside (+$36.75) to the $305 target
Cantor Fitzgerald Reiterated▲ Target raised
RatingOverweight unchanged
Price target$174 → $201 +15.5% · +$27
Price at note$158.18 (Oct 26 close) +27.1% upside (+$42.82) to the $201 target
LOWLowe's$198.18
Stifel Reiterated▼ Target lowered
RatingHold unchanged
Price target$220 → $195 −11.4% · −$25
Price at note$198.22 (Oct 26 close) −1.6% downside (−$3.22) to the $195 target
JP Morgan Reiterated▲ Target raised
RatingNeutral unchanged
Price target$620 → $665 +7.3% · +$45
Price at note$635.20 (Oct 26 close) +4.7% upside (+$29.80) to the $665 target
Morgan Stanley ▲ Upgrade▲ Target raised
RatingEqual-Weight▲Overweight
Price target$690 → $835 +21.0% · +$145
Price at note$635.20 (Oct 26 close) +31.5% upside (+$199.80) to the $835 target
BMO Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$82 → $64 −22.0% · −$18
Price at note$40.33 (Oct 26 close) +58.7% upside (+$23.67) to the $64 target
Goldman Sachs Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$15 → $6 −60.0% · −$9
Price at note$7.01 (Oct 26 close) −14.4% downside (−$1.01) to the $6 target
FIXComfort Systems USAOur stock$1,288.61
UBS Reiterated▼ Target lowered
RatingBuy unchanged
Price target$2,225 → $1,900 −14.6% · −$325
Price at note$1,244.19 (Oct 26 close) +52.7% upside (+$655.81) to the $1,900 target
FIXComfort Systems USAOur stock$1,288.61
Oppenheimer Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$2,400 → $2,000 −16.7% · −$400
Price at note$1,244.19 (Oct 26 close) +60.7% upside (+$755.81) to the $2,000 target
FIXComfort Systems USAOur stock$1,288.61
Keybanc Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$2,125 → $1,979 −6.9% · −$146
Price at note$1,244.19 (Oct 26 close) +59.1% upside (+$734.81) to the $1,979 target
FICOFair IsaacOur stock$691.74
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$1,100 → $942 −14.4% · −$158
Price at note$708.07 (Oct 26 close) +33.0% upside (+$233.93) to the $942 target
FICOFair IsaacOur stock$691.74
BMO Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$1,150 → $897 −22.0% · −$253
Price at note$708.07 (Oct 26 close) +26.7% upside (+$188.93) to the $897 target
FICOFair IsaacOur stock$691.74
JP Morgan Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$1,530 → $900 −41.2% · −$630
Price at note$708.07 (Oct 26 close) +27.1% upside (+$191.93) to the $900 target
FICOFair IsaacOur stock$691.74
Wells Fargo ▼ Downgrade▼ Target lowered
RatingOverweight▼Equal-Weight
Price target$800 → $735 −8.1% · −$65
Price at note$708.07 (Oct 26 close) +3.8% upside (+$26.93) to the $735 target
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$25 → $19 −24.0% · −$6
Price at note$16.26 (Oct 26 close) +16.9% upside (+$2.74) to the $19 target
GLJ Research Reiterated▼ Target lowered
RatingSell unchanged
Price target$24.47 → $21.49 −12.2% · −$2.98
Price at note$31.60 (Oct 23 close, before the note) −32.0% downside (−$10.11) to the $21.49 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$125 → $105 −16.0% · −$20
Price at note$99.53 (Oct 26 close) +5.5% upside (+$5.47) to the $105 target
Morgan Stanley Reiterated▲ Target raised
RatingUnderweight unchanged
Price target$76 → $83 +9.2% · +$7
Price at note$94.41 (Oct 26 close) −12.1% downside (−$11.41) to the $83 target
JP Morgan Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$52 → $48 −7.7% · −$4
Price at note$28.15 (Oct 26 close) +70.5% upside (+$19.85) to the $48 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$925 → $750 −18.9% · −$175
Price at note$692.13 (Oct 26 close) +8.4% upside (+$57.87) to the $750 target
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$1,155 → $840 −27.3% · −$315
Price at note$692.13 (Oct 26 close) +21.4% upside (+$147.87) to the $840 target
BSXBoston ScientificOur stock$45.06
Stifel Reiterated▼ Target lowered
RatingBuy unchanged
Price target$60 → $55 −8.3% · −$5
Price at note$45.58 (Oct 26 close) +20.7% upside (+$9.42) to the $55 target
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$77 → $88 +14.3% · +$11
Price at note$83.36 (Oct 26 close) +5.6% upside (+$4.64) to the $88 target
BNP Paribas Reiterated▲ Target raised
RatingNeutral unchanged
Price target$70 → $85 +21.4% · +$15
Price at note$83.36 (Oct 26 close) +2.0% upside (+$1.64) to the $85 target
TD Cowen ▲ Upgrade▲ Target raised
RatingHold▲Buy
Price target$77 → $95 +23.4% · +$18
Price at note$83.36 (Oct 26 close) +14.0% upside (+$11.64) to the $95 target
Morgan Stanley Reiterated▼ Target lowered
RatingEqual-Weight unchanged
Price target$82 → $79 −3.7% · −$3
Price at note$69.49 (Oct 26 close) +13.7% upside (+$9.51) to the $79 target

Friday · Oct 23, 2026

Mizuho Reiterated
RatingOutperform unchanged
Price target$200
Price at note$119.54 (Oct 23 close) +67.3% upside (+$80.46) to the $200 target
RBC Capital Reiterated▲ Target raised
RatingSector Perform unchanged
Price target$92 → $96 +4.3% · +$4
Price at note$112.49 (Oct 23 close) −14.7% downside (−$16.49) to the $96 target
Morgan Stanley Reiterated
RatingEqual-Weight unchanged
Price target$17
Price at note$14.06 (Oct 23 close) +20.9% upside (+$2.94) to the $17 target
JP Morgan Reiterated
RatingOverweight unchanged
Price target$16
Price at note$14.06 (Oct 23 close) +13.8% upside (+$1.94) to the $16 target
Keefe, Bruyette & Woods ▲ Upgrade
RatingMarket Perform▲Outperform
Price target$17
Price at note$14.06 (Oct 23 close) +20.9% upside (+$2.94) to the $17 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$1,395 → $1,450 +3.9% · +$55
Price at note$1,098.88 (Oct 23 close) +32.0% upside (+$351.12) to the $1,450 target
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$1,335 → $1,350 +1.1% · +$15
Price at note$1,098.88 (Oct 23 close) +22.9% upside (+$251.12) to the $1,350 target
RBC Capital Reiterated▲ Target raised
RatingOutperform unchanged
Price target$1,323 → $1,392 +5.2% · +$69
Price at note$1,098.88 (Oct 23 close) +26.7% upside (+$293.12) to the $1,392 target
Telsey Advisory Group Reiterated
RatingOutperform unchanged
Price target$40
Price at note$33.42 (Oct 23 close) +19.7% upside (+$6.58) to the $40 target
Morgan Stanley Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$110 → $112 +1.8% · +$2
Price at note$104.20 (Oct 23 close) +7.5% upside (+$7.80) to the $112 target
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$640 → $700 +9.4% · +$60
Price at note$584.22 (Oct 23 close) +19.8% upside (+$115.78) to the $700 target
Oppenheimer Reiterated▲ Target raised
RatingOutperform unchanged
Price target$550 → $650 +18.2% · +$100
Price at note$584.22 (Oct 23 close) +11.3% upside (+$65.78) to the $650 target
Piper Sandler Reiterated▲ Target raised
RatingNeutral unchanged
Price target$540 → $580 +7.4% · +$40
Price at note$584.22 (Oct 23 close) −0.7% downside (−$4.22) to the $580 target
JP Morgan Reiterated▲ Target raised
RatingOverweight unchanged
Price target$650 → $700 +7.7% · +$50
Price at note$584.22 (Oct 23 close) +19.8% upside (+$115.78) to the $700 target
Evercore ISI Group Reiterated▲ Target raised
RatingOutperform unchanged
Price target$700 → $750 +7.1% · +$50
Price at note$584.22 (Oct 23 close) +28.4% upside (+$165.78) to the $750 target
Wells Fargo Reiterated▲ Target raised
RatingOverweight unchanged
Price target$570 → $660 +15.8% · +$90
Price at note$584.22 (Oct 23 close) +13.0% upside (+$75.78) to the $660 target
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$565 → $650 +15.0% · +$85
Price at note$584.22 (Oct 23 close) +11.3% upside (+$65.78) to the $650 target
Rosenblatt Reiterated▲ Target raised
RatingNeutral unchanged
Price target$527 → $576 +9.3% · +$49
Price at note$584.22 (Oct 23 close) −1.4% downside (−$8.22) to the $576 target
Cantor Fitzgerald Reiterated▲ Target raised
RatingNeutral unchanged
Price target$490 → $550 +12.2% · +$60
Price at note$584.22 (Oct 23 close) −5.9% downside (−$34.22) to the $550 target
Mizuho Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$115 → $105 −8.7% · −$10
Price at note$100.80 (Oct 23 close) +4.2% upside (+$4.20) to the $105 target
Jefferies Reiterated▲ Target raised
RatingHold unchanged
Price target$40 → $75 +87.5% · +$35
Price at note$83.39 (Oct 23 close) −10.1% downside (−$8.39) to the $75 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$45 → $105 +133.3% · +$60
Price at note$83.39 (Oct 23 close) +25.9% upside (+$21.61) to the $105 target
Oppenheimer Reiterated▲ Target raised
RatingOutperform unchanged
Price target$85 → $110 +29.4% · +$25
Price at note$83.39 (Oct 23 close) +31.9% upside (+$26.61) to the $110 target
Piper Sandler Reiterated▲ Target raised
RatingNeutral unchanged
Price target$43 → $94 +118.6% · +$51
Price at note$83.39 (Oct 23 close) +12.7% upside (+$10.61) to the $94 target
Evercore ISI Group Reiterated▲ Target raised
RatingIn-Line unchanged
Price target$38 → $90 +136.8% · +$52
Price at note$83.39 (Oct 23 close) +7.9% upside (+$6.61) to the $90 target
Wells Fargo Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$65 → $85 +30.8% · +$20
Price at note$83.39 (Oct 23 close) +1.9% upside (+$1.61) to the $85 target
Morgan Stanley Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$41 → $91 +122.0% · +$50
Price at note$83.39 (Oct 23 close) +9.1% upside (+$7.61) to the $91 target
Needham Reiterated▲ Target raised
RatingBuy unchanged
Price target$85 → $110 +29.4% · +$25
Price at note$83.39 (Oct 23 close) +31.9% upside (+$26.61) to the $110 target
Truist Securities Reiterated▲ Target raised
RatingHold unchanged
Price target$53 → $58 +9.4% · +$5
Price at note$57.02 (Oct 23 close) +1.7% upside (+$0.98) to the $58 target
Piper Sandler Reiterated▲ Target raised
RatingOverweight unchanged
Price target$230 → $231 +0.4% · +$1
Price at note$196.75 (Oct 23 close) +17.4% upside (+$34.25) to the $231 target
PAYCPaycomOur stock$261.94
Guggenheim Reiterated▲ Target raised
RatingBuy unchanged
Price target$225 → $300 +33.3% · +$75
Price at note$274.59 (Oct 23 close) +9.3% upside (+$25.41) to the $300 target
Guggenheim Reiterated▲ Target raised
RatingBuy unchanged
Price target$125 → $175 +40.0% · +$50
Price at note$158.96 (Oct 23 close) +10.1% upside (+$16.04) to the $175 target
Morgan Stanley Reiterated
RatingOverweight unchanged
Price target$132
Price at note$102.56 (Oct 23 close) +28.7% upside (+$29.44) to the $132 target
JP Morgan Reiterated
RatingOverweight unchanged
Price target$122
Price at note$102.56 (Oct 23 close) +19.0% upside (+$19.44) to the $122 target
Wells Fargo Reiterated
RatingEqual-Weight unchanged
Price target$111
Price at note$102.56 (Oct 23 close) +8.2% upside (+$8.44) to the $111 target
Barclays Reiterated
RatingOverweight unchanged
Price target$121
Price at note$102.56 (Oct 23 close) +18.0% upside (+$18.44) to the $121 target
Jefferies ▲ Upgrade▲ Target raised
RatingHold▲Buy
Price target$130 → $135 +3.8% · +$5
Price at note$113.86 (Oct 23 close) +18.6% upside (+$21.14) to the $135 target
Keybanc Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$145 → $140 −3.4% · −$5
Price at note$113.86 (Oct 23 close) +23.0% upside (+$26.14) to the $140 target
Stephens & Co. ▲ Upgrade▲ Target raised
RatingEqual-Weight▲Overweight
Price target$130 → $135 +3.8% · +$5
Price at note$113.86 (Oct 23 close) +18.6% upside (+$21.14) to the $135 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$633 → $674 +6.5% · +$41
Price at note$623.60 (Oct 23 close) +8.1% upside (+$50.40) to the $674 target
UBS Reiterated▲ Target raised
RatingBuy unchanged
Price target$653 → $692 +6.0% · +$39
Price at note$604.18 (Oct 23 close) +14.5% upside (+$87.82) to the $692 target
Citigroup Reiterated▲ Target raised
RatingBuy unchanged
Price target$691 → $706 +2.2% · +$15
Price at note$604.18 (Oct 23 close) +16.9% upside (+$101.82) to the $706 target
RBC Capital Reiterated▲ Target raised
RatingSector Perform unchanged
Price target$550 → $600 +9.1% · +$50
Price at note$604.18 (Oct 23 close) −0.7% downside (−$4.18) to the $600 target
Barclays Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$554 → $560 +1.1% · +$6
Price at note$604.18 (Oct 23 close) −7.3% downside (−$44.18) to the $560 target
Citigroup Reiterated
RatingBuy unchanged
Price target$9
Price at note$5.07 (Oct 23 close) +77.5% upside (+$3.93) to the $9 target
Freedom Broker ▲ Upgrade▼ Target lowered
RatingHold▲Buy
Price target$1,200 → $1,100 −8.3% · −$100
Price at note$875.68 (Oct 23 close) +25.6% upside (+$224.32) to the $1,100 target
Truist Securities Reiterated▼ Target lowered
RatingHold unchanged
Price target$95 → $86 −9.5% · −$9
Price at note$82.82 (Oct 23 close) +3.8% upside (+$3.18) to the $86 target
Piper Sandler Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$303 → $279 −7.9% · −$24
Price at note$186.92 (Oct 23 close) +49.3% upside (+$92.08) to the $279 target
FTNTFortinetOur stock$185.00
JP Morgan Reiterated▲ Target raised
RatingUnderweight unchanged
Price target$118 → $140 +18.6% · +$22
Price at note$179.99 (Oct 23 close) −22.2% downside (−$39.99) to the $140 target
Canaccord Genuity Reiterated▼ Target lowered
RatingBuy unchanged
Price target$265 → $250 −5.7% · −$15
Price at note$172.75 (Oct 23 close) +44.7% upside (+$77.25) to the $250 target
TD Cowen Reiterated▼ Target lowered
RatingBuy unchanged
Price target$242 → $235 −2.9% · −$7
Price at note$172.75 (Oct 23 close) +36.0% upside (+$62.25) to the $235 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$48 → $50 +4.2% · +$2
Price at note$33.21 (Oct 23 close) +50.6% upside (+$16.79) to the $50 target
Barclays Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$53 → $51 −3.8% · −$2
Price at note$33.21 (Oct 23 close) +53.6% upside (+$17.79) to the $51 target
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$53 → $54 +1.9% · +$1
Price at note$50.79 (Oct 23 close) +6.3% upside (+$3.21) to the $54 target
Evercore ISI Group Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$47 → $40 −14.9% · −$7
Price at note$27.52 (Oct 23 close) +45.3% upside (+$12.48) to the $40 target
Mizuho Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$43 → $37 −14.0% · −$6
Price at note$27.52 (Oct 23 close) +34.4% upside (+$9.48) to the $37 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$116 → $118 +1.7% · +$2
Price at note$117.97 (Oct 23 close) +0.0% upside (+$0.03) to the $118 target
Oppenheimer Reiterated▲ Target raised
RatingOutperform unchanged
Price target$164 → $168 +2.4% · +$4
Price at note$117.97 (Oct 23 close) +42.4% upside (+$50.03) to the $168 target
Piper Sandler Reiterated▲ Target raised
RatingNeutral unchanged
Price target$125 → $126 +0.8% · +$1
Price at note$117.97 (Oct 23 close) +6.8% upside (+$8.03) to the $126 target
JP Morgan Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$136 → $135 −0.7% · −$1
Price at note$117.97 (Oct 23 close) +14.4% upside (+$17.03) to the $135 target
ARGXargenx SEOur stock$882.48
Morgan Stanley Reiterated
RatingOverweight unchanged
Price target$1,190
Price at note$873.71 (Oct 23 close) +36.2% upside (+$316.29) to the $1,190 target
ARGXargenx SEOur stock$882.48
Guggenheim Reiterated
RatingBuy unchanged
Price target$1,120
Price at note$873.71 (Oct 23 close) +28.2% upside (+$246.29) to the $1,120 target
ARGXargenx SEOur stock$882.48
Wells Fargo Reiterated
RatingOverweight unchanged
Price target$1,336
Price at note$873.71 (Oct 23 close) +52.9% upside (+$462.29) to the $1,336 target
ARGXargenx SEOur stock$882.48
Evercore ISI Group Reiterated
RatingOutperform unchanged
Price target$1,090
Price at note$873.71 (Oct 23 close) +24.8% upside (+$216.29) to the $1,090 target
ARGXargenx SEOur stock$882.48
Baird Reiterated
RatingNeutral unchanged
Price target$861
Price at note$873.71 (Oct 23 close) −1.5% downside (−$12.71) to the $861 target
DA Davidson Reiterated
RatingBuy unchanged
Price target$250
Price at note$210.62 (Oct 23 close) +18.7% upside (+$39.38) to the $250 target
UBS Reiterated
RatingNeutral unchanged
Price target$240
Price at note$210.62 (Oct 23 close) +13.9% upside (+$29.38) to the $240 target
Guggenheim Reiterated
RatingBuy unchanged
Price target$239
Price at note$210.62 (Oct 23 close) +13.5% upside (+$28.38) to the $239 target
AMGNAmgen$424.94
Oppenheimer Reiterated
RatingOutperform unchanged
Price target$480
Price at note$424.94 (Oct 19 close, before the note) +13.0% upside (+$55.06) to the $480 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$85 → $88 +3.5% · +$3
Price at note$70.08 (Oct 23 close) +25.6% upside (+$17.92) to the $88 target
ABBVAbbVie$286.39
Goldman Sachs Reiterated▲ Target raised
RatingNeutral unchanged
Price target$258 → $294 +14.0% · +$36
Price at note$285.64 (Oct 23 close) +2.9% upside (+$8.36) to the $294 target

Thursday · Oct 22, 2026

Freedom Broker Reiterated▲ Target raised
RatingBuy unchanged
Price target$230 → $270 +17.4% · +$40
Price at note$212.53 (Oct 19 close, before the note) +27.0% upside (+$57.47) to the $270 target
Baird Reiterated
RatingOutperform unchanged
Price target$150
Price at note$120.87 (Oct 22 close) +24.1% upside (+$29.13) to the $150 target
HSBC Initiated
RatingHold Initiated
Price target$106.50
Price at note$108.72 (Oct 21 close, before the note) −2.0% downside (−$2.22) to the $106.50 target
RBC Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$708 → $697 −1.6% · −$11
Price at note$584.79 (Oct 22 close) +19.2% upside (+$112.21) to the $697 target
UBS Reiterated▲ Target raised
RatingBuy unchanged
Price target$1,350 → $1,450 +7.4% · +$100
Price at note$1,111.02 (Oct 22 close) +30.5% upside (+$338.98) to the $1,450 target
Mizuho Reiterated▲ Target raised
RatingOutperform unchanged
Price target$493 → $500 +1.4% · +$7
Price at note$424.98 (Oct 22 close) +17.7% upside (+$75.02) to the $500 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$391 → $425 +8.7% · +$34
Price at note$374.58 (Oct 22 close) +13.5% upside (+$50.42) to the $425 target
CLSA ▲ Upgrade▲ Target raised
RatingUnderperform▲Hold
Price target$310 → $400 +29.0% · +$90
Price at note$374.58 (Oct 22 close) +6.8% upside (+$25.42) to the $400 target
Canaccord Genuity Reiterated▲ Target raised
RatingBuy unchanged
Price target$410 → $442 +7.8% · +$32
Price at note$374.58 (Oct 22 close) +18.0% upside (+$67.42) to the $442 target
Morgan Stanley Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$400 → $410 +2.5% · +$10
Price at note$374.58 (Oct 22 close) +9.5% upside (+$35.42) to the $410 target
BNP Paribas ▲ Upgrade▲ Target raised
RatingUnderperform▲Neutral
Price target$266 → $420 +57.9% · +$154
Price at note$374.58 (Oct 22 close) +12.1% upside (+$45.42) to the $420 target
RBC Capital Reiterated
RatingOutperform unchanged
Price target$480 unchanged
Price at note$374.58 (Oct 22 close) +28.1% upside (+$105.42) to the $480 target
JP Morgan Reiterated▲ Target raised
RatingNeutral unchanged
Price target$415 → $430 +3.6% · +$15
Price at note$374.58 (Oct 22 close) +14.8% upside (+$55.42) to the $430 target
TD Cowen Reiterated
RatingBuy unchanged
Price target$460 unchanged
Price at note$374.58 (Oct 22 close) +22.8% upside (+$85.42) to the $460 target
Piper Sandler Reiterated▲ Target raised
RatingOverweight unchanged
Price target$450 → $475 +5.6% · +$25
Price at note$374.58 (Oct 22 close) +26.8% upside (+$100.42) to the $475 target
StoneX Reiterated
RatingBuy unchanged
Price target$475 unchanged
Price at note$374.58 (Oct 22 close) +26.8% upside (+$100.42) to the $475 target
GLJ Research Reiterated
RatingSell unchanged
Price target$24.86 unchanged
Price at note$374.58 (Oct 22 close) −93.4% downside (−$349.72) to the $24.86 target
Mizuho Reiterated▲ Target raised
RatingOutperform unchanged
Price target$450 → $460 +2.2% · +$10
Price at note$374.58 (Oct 22 close) +22.8% upside (+$85.42) to the $460 target
Cantor Fitzgerald Reiterated
RatingOverweight unchanged
Price target$485 unchanged
Price at note$374.58 (Oct 22 close) +29.5% upside (+$110.42) to the $485 target
TLNTalen EnergyOur stock$345.73
TD Cowen Initiated
RatingBuy Initiated
Price target$475
Price at note$331.42 (Oct 22 close) +43.3% upside (+$143.58) to the $475 target
TLNTalen EnergyOur stock$345.73
HSBC Initiated
RatingBuy Initiated
Price target$444.30
Price at note$331.42 (Oct 22 close) +34.1% upside (+$112.88) to the $444.30 target
B. Riley Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$225 → $195 −13.3% · −$30
Price at note$128.89 (Oct 22 close) +51.3% upside (+$66.11) to the $195 target
JP Morgan ▼ Downgrade
RatingOverweight▼Neutral
Price target$52
Price at note$50.22 (Oct 22 close) +3.5% upside (+$1.78) to the $52 target
Citigroup Reiterated▲ Target raised
RatingBuy unchanged
Price target$245 → $250 +2.0% · +$5
Price at note$196.19 (Oct 22 close) +27.4% upside (+$53.81) to the $250 target
NOCNorthrop GrummanOur stock$551.23
Barclays Reiterated
RatingUnderweight unchanged
Price target$430
Price at note$552.35 (Oct 22 close) −22.2% downside (−$122.35) to the $430 target
Argus Research Reiterated▼ Target lowered
RatingBuy unchanged
Price target$120 → $95 −20.8% · −$25
Price at note$67.05 (Oct 22 close) +41.7% upside (+$27.95) to the $95 target
Pivotal Research Reiterated▼ Target lowered
RatingHold unchanged
Price target$70 → $65 −7.1% · −$5
Price at note$67.05 (Oct 22 close) −3.1% downside (−$2.05) to the $65 target
Freedom Broker Reiterated▼ Target lowered
RatingBuy unchanged
Price target$80 → $76 −5.0% · −$4
Price at note$57.62 (Oct 21 close, before the note) +31.9% upside (+$18.38) to the $76 target
B. Riley Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$108 → $98 −9.3% · −$10
Price at note$74.52 (Oct 22 close) +31.5% upside (+$23.48) to the $98 target
Freedom Broker ▲ Upgrade▲ Target raised
RatingHold▲Buy
Price target$37 → $40 +8.1% · +$3
Price at note$33.19 (Oct 22 close) +20.5% upside (+$6.81) to the $40 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$42 → $41 −2.4% · −$1
Price at note$33.19 (Oct 22 close) +23.5% upside (+$7.81) to the $41 target
Citizens Reiterated▼ Target lowered
RatingMarket Outperform unchanged
Price target$24 → $14 −41.7% · −$10
Price at note$7.24 (Oct 22 close) +93.4% upside (+$6.76) to the $14 target
Mizuho Reiterated▲ Target raised
RatingNeutral unchanged
Price target$42 → $44 +4.8% · +$2
Price at note$33.11 (Oct 22 close) +32.9% upside (+$10.89) to the $44 target
HSBC Initiated
RatingHold Initiated
Price target$123
Price at note$121.07 (Oct 21 close, before the note) +1.6% upside (+$1.93) to the $123 target
UBS Reiterated▲ Target raised
RatingBuy unchanged
Price target$54 → $60 +11.1% · +$6
Price at note$51.67 (Oct 22 close) +16.1% upside (+$8.33) to the $60 target
B of A Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$55 → $57 +3.6% · +$2
Price at note$51.67 (Oct 22 close) +10.3% upside (+$5.33) to the $57 target
RBC Capital Reiterated▲ Target raised
RatingOutperform unchanged
Price target$53 → $54 +1.9% · +$1
Price at note$51.67 (Oct 22 close) +4.5% upside (+$2.33) to the $54 target
TD Cowen Reiterated▲ Target raised
RatingBuy unchanged
Price target$54 → $55 +1.9% · +$1
Price at note$51.67 (Oct 22 close) +6.4% upside (+$3.33) to the $55 target
JP Morgan Reiterated▲ Target raised
RatingOverweight unchanged
Price target$57 → $58 +1.8% · +$1
Price at note$51.67 (Oct 22 close) +12.3% upside (+$6.33) to the $58 target
Morgan Stanley Reiterated
RatingUnderweight unchanged
Price target$93
Price at note$111.98 (Oct 22 close) −16.9% downside (−$18.98) to the $93 target
Cantor Fitzgerald Initiated
RatingOverweight Initiated
Price target$140
Price at note$65.57 (Oct 22 close) +113.5% upside (+$74.43) to the $140 target
BMO Capital Reiterated
RatingOutperform unchanged
Price target$91
Price at note$78.83 (Oct 22 close) +15.4% upside (+$12.17) to the $91 target
BIIBBiogen$252.73
B of A Securities Reiterated
RatingNeutral unchanged
Price target$244
Price at note$253.84 (Oct 22 close) −3.9% downside (−$9.84) to the $244 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$148 → $100 −32.4% · −$48
Price at note$91.13 (Oct 22 close) +9.7% upside (+$8.87) to the $100 target

Source: Yahoo Finance analyst upgrades and downgrades (firm, rating, price target), refreshed after each US market close for the stocks SURVYR. covers. Yahoo doesn't name the individual analyst. "Price at note" is that day's closing price from our daily price history (the prior close when the note came before the open); the upside or downside is the distance from it to the new target. Details opens the matching news story when we have one, otherwise the stock's Yahoo Finance analysis page. Ratings and targets belong to the firms named; SURVYR. doesn't rate stocks, set targets or give advice. Not investment advice · Important disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026